期刊
NATURE REVIEWS CANCER
卷 14, 期 11, 页码 747-753出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3819
关键词
-
类别
资金
- Cancer Research UK [A13086]
- Ovarian Cancer Action, London, UK
- Cancer Research UK [13086, 15954] Funding Source: researchfish
- Ovarian Cancer Action [OCA3] Funding Source: researchfish
Epigenetic events, which are somatically inherited through cell division, are potential drivers of acquired drug resistance in cancer. The high rate of epigenetic change in tumours generates diversity in gene expression patterns that can rapidly evolve through drug selection during treatment, leading to the development of acquired resistance. This will potentially confound stratified chemotherapy decisions that are solely based on mutation biomarkers. Poised epigenetic states in tumour cells may drive multistep epigenetic fixation of gene expression during the acquisition of drug resistance, which has implications for clinical strategies to prevent the emergence of drug resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据